Rocket Lab (RKLB) shares have experienced a sharp pullback, falling 31% from their all-time high to trade near $104. The decline has erased approximately $27 billion in market capitalization, bringing the company's valuation from $87 billion to $60 billion. The retreat is part of a broader sell-off in space-related equities following the highly anticipated SpaceX IPO, which saw investors rotate out of the sector after a prolonged rally.

Profit-Taking Hits Space Stocks

The downturn is not isolated to Rocket Lab. Planet Labs has dropped 45% from its year-to-date high, while Intuitive Machines, Redwire, and Virgin Galactic have each fallen more than 50% from their 2025 peaks. The Procure Space ETF (UFO), which surged from $15 in April 2024 to $68.3, has also corrected. This pattern suggests a classic 'buy the rumor, sell the news' dynamic, where investors accumulated space stocks ahead of the SpaceX listing and are now taking profits.

Read also
Stocks
AMC Stock Nears Golden Cross as Box Office Rebounds, Dilution Risk Looms
AMC Entertainment's stock has rallied 165% from its year-to-date low and is nearing a golden cross pattern. While box office recovery fuels optimism, persistent share dilution poses a significant risk.

Fundamentals Remain Strong

Despite the price weakness, Rocket Lab's underlying business continues to show robust growth. First-quarter revenue rose 63% year-over-year to $200.3 million, compared to just $61 million for all of 2021. Gross margin expanded to 38.2%, and the company secured 31 new contracts for its Electron and HASTE vehicles during the quarter. The backlog of Neutron product contracts also increased.

Analysts expect second-quarter revenue of $231 million, representing 60% annual growth. Full-year 2025 revenue is projected at $914 million, up 51%, with estimates of $1.29 billion in 2026. If the trajectory holds, revenue could reach $5 billion by 2030, driven largely by the Neutron rocket, which has a payload capacity of 13,000 kilograms and is designed for reusability.

Valuation and Dilution Risks

Investors should be aware of two key risks. First, Rocket Lab has consistently increased its share count, from 460 million outstanding shares in early 2024 to 575 million today. The company raised $2 billion through equity offerings last year. Second, the forward price-to-sales ratio stands at approximately 70, a level that some analysts consider elevated relative to peers. However, firms like KeyCorp and Stifel have maintained price targets of $135 and $132, respectively, implying potential upside from current levels.

Technical Analysis Points to Potential Reversal

From a technical perspective, RKLB has broken below its 25-day exponential moving average (EMA), and the Average Directional Index (ADX) has declined from 43 to 26, indicating that the downtrend is losing momentum. Notably, the stock has formed a rising broadening wedge pattern, which is often interpreted as a bullish continuation signal.

Two scenarios are possible: the stock could continue to decline toward the lower boundary of the wedge near $80 before rebounding, or a break below that level would signal further downside, potentially to $50. The wedge pattern suggests that the current pullback may be a consolidation phase before the next leg higher, but confirmation requires a move above the wedge's upper trendline.

For context, broader market headwinds, including rising bond yields and tech sector volatility, have also weighed on sentiment, as discussed in our analysis of the Dow Jones facing key headwinds. Meanwhile, other high-growth names like Webull stock have shown similar patterns of sharp declines followed by potential reversals.

This article is for informational purposes only and does not constitute financial advice.